Abstract
The article presents clinical observation of the patient at the age of 7 years suffering from severe juvenile idiopathic arthritis with uveitis refractory to standard antirheumatic therapy. The case complexity was determined by multiple joint damages, presence of bilateral uveitis, and hyperimmunoglobulinemia at the disease onset. The successful use of abatacept is described: remission from both the articular syndrome and uveitis, a 100% improvement by ACRpedi criteria are reached. The selection of a biological preparation was determined by a polyarticular joint disease, by the presence of active recurrent uveitis, as well as by immune status compromise for TB infection. A gradual increase in abatacept efficacy and remission maintenance for a long time period are demonstrated.
Highlights
Представлено клиническое наблюдение пациентки в возрасте 7 лет, страдающей тяжелым ювенильным идиопатическим артритом с увеитом, рефрактерным к стандартной противоревматической терапии
The article presents clinical observation of the patient at the age of 7 years suffering from severe juvenile idiopathic arthritis with uveitis refractory to standard antirheumatic therapy
The case complexity was determined by multiple joint damages, presence of bilateral uveitis, and hyperimmunoglobulinemia at the disease onset
Summary
Представлено клиническое наблюдение пациентки в возрасте 7 лет, страдающей тяжелым ювенильным идиопатическим артритом с увеитом, рефрактерным к стандартной противоревматической терапии. (For citation: Galstian Lelia A., Zholobova Elena S., Starikova Alexandra V., Denisova Ekaterina V. Efficacy of Abatacept Therapy in a Patient with Juvenile Idiopathic Arthritis and Bilateral Uveitis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have